Institutional Ownership Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE). We have compiled data on the 348 institutions that hold shares in the stock, with a total of 88.2 Million shares, which have been reported (via 13F filing form) to have a value of $2.92 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
750,000
shares
|
$24.8 Million
1.02% of portfolio
|
Q3 2025
New holding
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
746,182
shares
|
$24.7 Million
0.01% of portfolio
|
Q3 2025
Added 195.71%
|
|
|
Eagle Health Investments LP
Greenwich, CT |
Nov 07, 2025 Q3 2025 |
697,000
shares
|
$23.1 Million
5.59% of portfolio
|
Q3 2025
Added 11.06%
|
|
|
Nuveen, LLC
Charlotte, NC |
Nov 12, 2025 Q3 2025 |
682,144
shares
|
$22.6 Million
0.01% of portfolio
|
Q3 2025
Added 35.04%
|
|
|
Franklin Resources Inc
San Mateo, CA |
Nov 13, 2025 Q3 2025 |
677,184
shares
|
$22.4 Million
0.01% of portfolio
|
Q3 2025
Added 42.52%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
655,021
shares
|
$21.7 Million
0.0% of portfolio
|
Q3 2025
Added 2.72%
|
|
|
Driehaus Capital Management LLC
Chicago, IL |
Nov 14, 2025 Q3 2025 |
603,397
shares
|
$20 Million
0.15% of portfolio
|
Q3 2025
Reduced 0.5%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
600,160
shares
|
$19.9 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.57%
|
|
|
Braidwell LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
588,700
shares
|
$19.5 Million
1.02% of portfolio
|
Q3 2025
New holding
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2025 Q3 2025 |
583,710
shares
|
$19.3 Million
0.09% of portfolio
|
Q3 2025
Added 5.86%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
582,976
shares
|
$19.3 Million
0.03% of portfolio
|
Q2 2023
Added 74.53%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
547,025
shares
|
$18.1 Million
0.0% of portfolio
|
Q3 2025
Added 24.2%
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
Nov 14, 2025 Q3 2025 |
531,996
shares
|
$17.6 Million
0.05% of portfolio
|
Q3 2025
Reduced 62.78%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2025 Q3 2025 |
517,700
shares
|
$17.1 Million
0.03% of portfolio
|
Q3 2025
Reduced 39.83%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Oct 29, 2025 Q3 2025 |
501,163
shares
|
$16.6 Million
0.0% of portfolio
|
Q3 2025
Added 2.99%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
499,232
shares
|
$16.5 Million
0.0% of portfolio
|
Q3 2025
Added 1.17%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Nov 03, 2025 Q3 2025 |
496,060
shares
|
$16.4 Million
0.03% of portfolio
|
Q3 2025
Reduced 75.8%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2025 Q3 2025 |
482,582
shares
|
$16 Million
0.05% of portfolio
|
Q3 2025
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
476,938
shares
|
$15.8 Million
0.0% of portfolio
|
Q3 2025
Added 11.96%
|
|
|
Fred Alger Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
448,717
shares
|
$14.8 Million
0.06% of portfolio
|
Q3 2025
Added 4.27%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
430,000
shares
|
$14.2 Million
0.02% of portfolio
|
Q3 2025
Reduced 71.89%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
425,351
shares
|
$14.1 Million
0.0% of portfolio
|
Q3 2025
Added 138.14%
|
|
|
Blue Owl Capital Holdings LP
New York, NY |
Nov 12, 2025 Q3 2025 |
422,438
shares
|
$14 Million
5.51% of portfolio
|
Q3 2025
Added 65.51%
|
|
|
Emerald Advisers, LLC
|
Oct 30, 2025 Q3 2025 |
418,566
shares
|
$13.8 Million
0.43% of portfolio
|
Q3 2025
Reduced 9.28%
|
|
|
Axa Investment Managers S.A.
Puteaux, I0 |
Nov 14, 2025 Q3 2025 |
417,198
shares
|
$13.8 Million
0.04% of portfolio
|
Q3 2025
New holding
|
|